Literature DB >> 23103552

Transcriptional dysregulation and impairment of PHOX2B auto-regulatory mechanism induced by polyalanine expansion mutations associated with congenital central hypoventilation syndrome.

Simona Di Lascio1, Tiziana Bachetti, Elena Saba, Isabella Ceccherini, Roberta Benfante, Diego Fornasari.   

Abstract

The PHOX2B transcription factor plays a crucial role in autonomic nervous system development. In humans, heterozygous mutations of the PHOX2B gene lead to congenital central hypoventilation syndrome (CCHS), a rare disorder characterized by a broad variety of symptoms of autonomic nervous system dysfunction including inadequate control of breathing. The vast majority of patients with CCHS are heterozygous for a polyalanine repeat expansion mutation involving a polyalanine tract of twenty residues in the C-terminus of PHOX2B. Although several lines of evidence support a dominant-negative mechanism for PHOX2B mutations in CCHS, the molecular effects of PHOX2B mutant proteins on the transcriptional activity of the wild-type protein have not yet been elucidated. As one of the targets of PHOX2B is the PHOX2B gene itself, we tested the transcriptional activity of wild-type and mutant proteins on the PHOX2B gene promoter, and found that the transactivation ability of proteins with polyalanine expansions decreased as a function of the length of the expansion, whereas DNA binding was severely affected only in the case of the mutant with the longest polyalanine tract (+13 alanine). Co-transfection experiments using equimolar amounts of PHOX2B wild-type and mutant proteins in order to simulate a heterozygous state in vitro and four different PHOX2B target gene regulatory regions (PHOX2B, PHOX2A, DBH, TLX2) clearly showed that the polyalanine expanded proteins alter the transcriptional activity of wild-type protein in a promoter-specific manner, without any clear correlation with the length of the expansion. Moreover, although reduced transactivation may be caused by retention of the wild-type protein in the cytoplasm or in nuclear aggregates, this mechanism can only be partially responsible for the pathogenesis of CCHS because of the reduction in cytoplasmic and nuclear accumulation when the +13 alanine mutant is co-expressed with wild-type protein, and the fact that the shortest polyalanine expansions do not form visible cytoplasmic aggregates. Deletion of the C-terminal of PHOX2B leads to a protein that correctly localizes in the nucleus but impairs PHOX2B wild-type transcriptional activity, thus suggesting that protein mislocalization is not the only mechanism leading to CCHS. The results of this study provide novel in vitro experimental evidence of a transcriptional dominant-negative effect of PHOX2B polyalanine mutant proteins on wild-type protein on two different PHOX2B target genes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23103552     DOI: 10.1016/j.nbd.2012.10.019

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  10 in total

1.  Expanding the phenotype of congenital central hypoventilation syndrome impacts management decisions.

Authors:  Heather M Byers; Maida Chen; Andrew S Gelfand; Bruce Ong; Marisa Jendras; Ian A Glass
Journal:  Am J Med Genet A       Date:  2018-04-25       Impact factor: 2.802

2.  A Novel c.676_677insG PHOX2B Mutation in Congenital Central Hypoventilation Syndrome.

Authors:  Guodong Ye; Daxiong Han; Yu Jiang; Zengge Wang; Yulin Zhou; Xinzhu Lin; Weiwei Chen; Maoli Chen; Jianxiong Xu; Yanyan Yang; Qiwei Guo
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

Review 3.  Neuroblastoma: molecular pathogenesis and therapy.

Authors:  Chrystal U Louis; Jason M Shohet
Journal:  Annu Rev Med       Date:  2014-10-27       Impact factor: 13.739

4.  Nonsense pathogenic variants in exon 1 of PHOX2B lead to translational reinitiation in congenital central hypoventilation syndrome.

Authors:  Jacob T Cain; Dae I Kim; Megan Quast; Winnie G Shivega; Ryan J Patrick; Chuanpit Moser; Suzanne Reuter; Myrza Perez; Angela Myers; Jill M Weimer; Kyle J Roux; Megan Landsverk
Journal:  Am J Med Genet A       Date:  2017-03-29       Impact factor: 2.802

5.  Etonogestrel Administration Reduces the Expression of PHOX2B and Its Target Genes in the Solitary Tract Nucleus.

Authors:  Silvia Cardani; Tara A Janes; Jasmeen K Saini; Simona Di Lascio; Roberta Benfante; Diego Fornasari; Silvia Pagliardini
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

6.  Key Role of Amino Acid Repeat Expansions in the Functional Diversification of Duplicated Transcription Factors.

Authors:  Núria Radó-Trilla; Krisztina Arató; Cinta Pegueroles; Alicia Raya; Susana de la Luna; M Mar Albà
Journal:  Mol Biol Evol       Date:  2015-04-29       Impact factor: 16.240

7.  Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome.

Authors:  Simona Di Lascio; Roberta Benfante; Eleonora Di Zanni; Silvia Cardani; Annalisa Adamo; Diego Fornasari; Isabella Ceccherini; Tiziana Bachetti
Journal:  Hum Mutat       Date:  2017-11-21       Impact factor: 4.878

Review 8.  The genetics of congenital central hypoventilation syndrome: clinical implications.

Authors:  John Bishara; Thomas G Keens; Iris A Perez
Journal:  Appl Clin Genet       Date:  2018-11-15

Review 9.  Research Advances on Therapeutic Approaches to Congenital Central Hypoventilation Syndrome (CCHS).

Authors:  Simona Di Lascio; Roberta Benfante; Silvia Cardani; Diego Fornasari
Journal:  Front Neurosci       Date:  2021-01-12       Impact factor: 4.677

10.  Alanine Expansions Associated with Congenital Central Hypoventilation Syndrome Impair PHOX2B Homeodomain-mediated Dimerization and Nuclear Import.

Authors:  Simona Di Lascio; Debora Belperio; Roberta Benfante; Diego Fornasari
Journal:  J Biol Chem       Date:  2016-04-27       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.